Atlantic Health Strategies

Insights and Perspectives

Your Source For The Latest In Behavioral Health Compliance and Strategic Growth:

FDA Fast-Tracks Psychedelic Treatment for Resistant Depression

atai Life Sciences and Beckley Psytech recently announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to BPL-003, a nasal spray formulation of mebufotenin benzoate, for adults with treatment-resistant depression. While press releases often overstate scientific milestones,…

Read More »

OpenAI Eyes Therapist Network

OpenAI has publicly confirmed that it is exploring the creation of a network of licensed therapists that ChatGPT could refer users to directly. The goal is to “intervene earlier and connect people to certified therapists before they are in an…

Read More »

What’s New: Joint Commission Behavioral Health Standards Update

The Joint Commission recently implemented a series of updates to its Behavioral Health and Human Services standards. These changes, which took effect throughout 2025, affect emergency management, restraint and seclusion, infection control, opioid treatment oversight, and administrative participation in accreditation….

Read More »
Scroll to Top